Product Images Pregabalin
View Photos of Packaging, Labels & Appearance
- Remedy_Label - Remedy Label
- pregabalin-equation - pregabalin equation
- pregabalin-Figure-6 - pregabalin figure 6
- pregabalin-Figure-7 - pregabalin figure 7
- Study DPN 1 - pregabalin image 1
- Study SCI 1 - pregabalin image 10
- Pain Intensity-study SCI 2 - pregabalin image 11
- Study DPN 2 - pregabalin image 2
- Study PHN 1 - pregabalin image 3
- Study PHN 2 - pregabalin image 4
- Study PHN 3 - pregabalin image 5
- Fibromyalgia Study F1 - pregabalin image 8
- Fibromyalgia Study F2 - pregabalin image 9
- Pregabalin structure - pregabalin srtuc 1
Product Label Images
The following 14 images provide visual information about the product associated with Pregabalin NDC 70518-3597 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Remedy_Label - Remedy Label
This is a prescription medication called Pregabalin with a strength of 75 mg. The package contains 90 capsules and should be stored in tight containers at a temperature between 15-30°C. It is manufactured by Ascend Labs, LLC in Montvale, NJ and repackaged by RemedyRepack Inc. Detailed directions are provided in the package insert. The expiration date and lot number are not available in this text.*
pregabalin-equation - pregabalin equation
This appears to be a calculation formula for estimating creatinine clearance (CLCr), which is a measure of kidney function. The formula takes into account the patient's age, weight, and serum creatinine levels. However, the text is incomplete and lacks further context, therefore it is difficult to provide a full description or interpretation of its use.*
pregabalin-Figure-6 - pregabalin figure 6
The text describes the results of two studies (Study E1 and Study E3) on a certain treatment. The text includes percentages and numeric values for different dosages of the treatment and the placebo. The text also mentions that the treatment was found to be statistically significant compared to the placebo.*
pregabalin-Figure-7 - pregabalin figure 7
This is a statistical table with different p-values and values related to different studies. The data seems related to clinical trials testing the efficacy of a drug. The only information provided is the significant p-values. Therefore, it is not possible to provide a detailed description or conclusion about the study or the drug.*
Study DPN 1 - pregabalin image 1
Study SCI 1 - pregabalin image 10
Pain Intensity-study SCI 2 - pregabalin image 11
Study DPN 2 - pregabalin image 2
Study PHN 1 - pregabalin image 3
Study PHN 2 - pregabalin image 4
Percentage improvement in pain from baseline. The rest of the text is not readable or available.*
Study PHN 3 - pregabalin image 5
Fibromyalgia Study F1 - pregabalin image 8
This is a chart showing the percent improvement in pain for patients taking different doses of Pregabalin. The highest improvement was seen in patients taking a 600mg daily dose, followed by those taking a 450mg daily dose, then a 300mg daily dose, and finally patients taking a placebo. No further information is available.*
Fibromyalgia Study F2 - pregabalin image 9
Pregabalin structure - pregabalin srtuc 1
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
